CVD is the leading cause of death in the US. Hypertension and diabetes are among the foremost risk factors for the development of CVD, stroke, peripheral artery disease, and heart attack. This program will provide an overview of recent advances that target the underlying pathophysiology of cardiovascular disease. The focus of the program will be on the new guidelines for hypertension, DM and CKD and will discuss the advances in pharmacotherapeutics in these fields.

Glomerular disease is associated with morbidity and mortality in patients of all ages and is a common cause of end stage kidney disease. These include those that commonly present with nephrotic syndrome (minimal change disease, FSGS and membranous nephropathy), the nephrotic syndrome (vasculitis, lupus nephritis and IgA nephropathy), among others. Treatment often utilizes immunosuppressive regimens such as high dose corticosteroids, alkylating agents, calcineurin inhibitors, biologics and anti...

In the last few years, there has been dramatic advancement in the diagnostic tools and treatment options available for neuromuscular disorders. While this is a welcome development, it may be challenging for neurologists taking care of patients with neuromuscular disorders to keep up to date with all of these advances. The purpose of the Penn Neuromuscular Symposium is to provide both a basic approach to patients with neuromuscular disorders and an update on novel therapeutic agents and future di...

The list of course topics and subtopics was adapted from the ABPN’s description of the board and recertification examinations. The time allotted for each topic is based upon the approximate distribution of the subject matter as given by the ABPN. Our course will provide an excellent review of board exam and recertification topics primarily through case-based learning and help the learner identify areas that require further study. The learner can then review and prepare further in these areas pri...

The Clinical Research Operations Supplemental Series (CROSS) provides educational opportunities for research staff of the Abramson Cancer Center (ACC) Clinical Research Unit (CRU) on topics related to the daily operations of the ACC CRU and collaborating departments, e.g., Radiation Oncology, Pathology, Fertility Preservation Care Program. Past educational opportunities have included: (1) Hallmarks of Cancer, (2) Drug-Drug Interactions: The Cytochrome 450 Metabolic Pathway, and (3) Immune Toxic...

Preliminary outcomes of the new UNOS kidney allocation policy will be reviewed as well as unintended outcomes that are impacting patients in the greater Philadelphia region. The evolution of the allocation policies will be discussed. Effective strategies to decrease waiting time will be highlighted.

This will be a half day medical education course designed to empower clinician educators with new skills focusing on coaching and using innovative assessment mechanisms that are applicable to any specialty. It will also be a forum to build the clinician educator community, troubleshoot educational challenges, and collaborate on new projects.This activity is designed for Physicians only.

To help provide an environment where patient care is the main priority and residents, fellows, and other members of the interprofessional healthcare team are able to provide quality patient care. Quality patient care will be assured through review of peer-reviewed literature, multidisciplinary cooperation, and following of established clinical practice guidelines.

These sessions will bring content experts from many aspects of the University including Penn Medicine and CHOP to address relevant and contemporary issues in delivering care to medically underserved patient populations.

This activity is designed to provide evidence-based recommendations for the care of our Emergency Department patient population who are facing substance abuse issues.